Skip to main content

Site notifications

AusPAR: Nuvaxovid

Australian Public Assessment Report
Device/Product Name
NUVAXOVID
Active ingredients
SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 vaccine
AusPAR Date
Published
Submission Number
PM-2023-00909-1-2
Submission Type
Major variation (new dosage regimen)
Decision
Approved

Help us improve the Therapeutic Goods Administration site